Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Label: Wegovy semaglutide injection solution and Wegovy semaglutide tablet
No known contraindication, and Mayo Clinic ENDO 2025 (120 postmenopausal women) showed tirzepatide plus HRT produced 17% weight loss vs 14% for tirzepatide alone
Key findings: Pharmacokinetics were dose proportional Steady-state exposures were maintained with once-weekly dosing Body weight reduction was dose-dependent: up to -8.96 kg in the highest dose group vs placebo at 12 weeks HbA1c reductions of -0.4% to -1.2% across dose groups Safety profile consistent with other incretin drugs (GI adverse events most common) Drug Interactions and Kidney Function: What Has Been Studied oral drug taken alongside it
Book an appointment now
Patients should share their meal logs with their healthcare provider at follow-up appointments, particularly during dose escalation periods when eating patterns typically change most dramatically
How should doctors counsel their patients about peptides that have not been FDA approved
